{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:44:31Z","timestamp":1790286271691,"version":"4.1.0"},"reference-count":66,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Radiation therapy has been progressively improved in order to maintain a satisfactory tumour response, while reducing toxicity. We will review the incidence of radiodermatitis and fibrosis according to the various radiation and fractionation techniques. We will then focus on the various methods used to manage, prevent, and quantify this toxicity. Method: More than 1753 articles were identified using the various search terms. We selected 53 articles to answer the questions addressed in this study according to criteria set in advance. Result: The literature reports lower acute toxicity with IMRT compared to 3DCRT, but no significant differences in terms of late toxicities. Partial breast irradiation appears to be less effective in terms of local control with a higher rate of late toxicity. Intra operative radiation therapy appears to provide good results in terms of both local control and late toxicity. The hypofractionation has equivalent efficacy and safety to the normofractionated regimen, but with lower rates of radiodermatitis and fibrosis. The adddition of a boost, particularly a sequential boost, increases the risk of fibrosis and radiodermatitis during treatment. Conclusion: The development of IMRT has significantly reduced acute toxicity and has improved tolerability during treatment. Modified fractionation has reduced treatment time, as well as adverse effects.<\/jats:p>","DOI":"10.3390\/cancers13235928","type":"journal-article","created":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T22:19:16Z","timestamp":1638137956000},"page":"5928","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Radiodermatitis and Fibrosis in the Context of Breast Radiation Therapy: A Critical Review"],"prefix":"10.3390","volume":"13","author":[{"given":"Sofiane","family":"Allali","sequence":"first","affiliation":[{"name":"Radiation Therapy Department, Institut Curie, CEDEX 05, 75248 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1795-7509","authenticated-orcid":false,"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[{"name":"Radiation Therapy Department, Institut Curie, CEDEX 05, 75248 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/028418600750013249","article-title":"Conformal Radiotherapy and Intensity-Modulated Radiotherapy--Clinical Data","volume":"39","author":"Tubiana","year":"2000","journal-title":"Acta Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0167-8140(91)90160-I","article-title":"Breast Irradiation in the Lateral Decubitus Position: Technique of the Institut Curie","volume":"22","author":"Fourquet","year":"1991","journal-title":"Radiother. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fonc.2018.00087","article-title":"Deep Inspiration Breath Hold: Techniques and Advantages for Cardiac Sparing During Breast Cancer Irradiation","volume":"8","author":"Bergom","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13014-019-1430-x","article-title":"Dose Reduction to Organs at Risk with Deep-Inspiration Breath-Hold during Right Breast Radiotherapy: A Treatment Planning Study","volume":"14","author":"Pandeli","year":"2019","journal-title":"Radiat. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and Reliability of the US National Cancer Institute\u2019s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_7","unstructured":"Savarese, D.M. (2013). Common Terminology Criteria for Adverse Events, UpToDate Waltham."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaad.2005.08.054","article-title":"Radiation Dermatitis: Clinical Presentation, Pathophysiology, and Treatment 2006","volume":"54","author":"Hymes","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s40257-016-0186-4","article-title":"Radiodermatitis: A Review of Our Current Understanding","volume":"17","author":"Singh","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"109560","DOI":"10.1016\/j.biopha.2019.109560","article-title":"Advances in Pathogenic Mechanisms and Management of Radiation-Induced Fibrosis","volume":"121","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00432-015-1974-6","article-title":"Radiation-Induced Fibrosis: Mechanisms and Implications for Therapy","volume":"141","author":"Straub","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.canrad.2016.07.025","article-title":"Radiotherapy of breast cancer","volume":"20","author":"Hennequin","year":"2016","journal-title":"Cancer Radiother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1200\/JCO.2007.15.2488","article-title":"A Multicenter Randomized Trial of Breast Intensity-Modulated Radiation Therapy to Reduce Acute Radiation Dermatitis","volume":"26","author":"Pignol","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13014-020-01652-x","article-title":"Acute Toxicity of Normofractionated Intensity Modulated Radiotherapy with Simultaneous Integrated Boost Compared to Three-Dimensional Conformal Radiotherapy with Sequential Boost in the Adjuvant Treatment of Breast Cancer","volume":"15","author":"Krug","year":"2020","journal-title":"Radiat. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ijrobp.2020.12.005","article-title":"Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial)","volume":"109","author":"Forster","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Askoxylakis, V., Jensen, A.D., H\u00e4fner, M.F., Fetzner, L., Sterzing, F., Heil, J., Sohn, C., H\u00fcsing, J., Tiefenbacher, U., and Wenz, F. (2011). Simultaneous Integrated Boost for Adjuvant Treatment of Breast Cancer--Intensity Modulated vs. Conventional Radiotherapy: The IMRT-MC2 Trial. BMC Cancer, 11.","DOI":"10.1186\/1471-2407-11-249"},{"key":"ref_17","unstructured":"(1995). LENT SOMA Tables. Radiother. Oncol., 35, 17\u201360."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4329\/wjr.v8.i8.735","article-title":"Helical Tomotherapy and Volumetric Modulated Arc Therapy: New Therapeutic Arms in the Breast Cancer Radiotherapy","volume":"8","author":"Lauche","year":"2016","journal-title":"World J. Radiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1038\/s41598-020-61403-6","article-title":"Five-Year Survival Outcomes of Intensity-Modulated Radiotherapy with Simultaneous Integrated Boost (IMRT-SIB) Using Forward IMRT or Tomotherapy for Breast Cancer","volume":"10","author":"Lee","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clon.2020.07.005","article-title":"Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled Trial","volume":"33","author":"Joseph","year":"2021","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hickey, B.E., Lehman, M., Francis, D.P., and See, A.M. (2016). Partial Breast Irradiation for Early Breast Cancer. Cochrane Database Syst. Rev., CD007077.","DOI":"10.1002\/14651858.CD007077.pub3"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lehman, M., Hickey, B.E., Francis, D.P., and See, A.M. (2014). Partial Breast Irradiation for Early Breast Cancer. Cochrane Database Syst. Rev., CD007077.","DOI":"10.1002\/14651858.CD007077.pub2"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/GCO.0b013e32834d4aaf","article-title":"Partial Breast Radiation for Early-Stage Breast Cancer","volume":"24","author":"McCormick","year":"2012","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.brachy.2020.03.003","article-title":"Partial-Breast Irradiation versus Whole-Breast Radiotherapy for Early Breast Cancer: A Systematic Review and Update Meta-Analysis","volume":"19","author":"Viani","year":"2020","journal-title":"Brachytherapy"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/tbj.13767","article-title":"Analysis of Breast Cosmetic Effects 3 Years after Breast-Conserving Surgery and Intraoperative Radiotherapy with and without Adjuvant Whole Breast Irradiation","volume":"26","author":"Falco","year":"2020","journal-title":"Breast J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1245\/s10434-017-5920-5","article-title":"Cosmetic Outcome and Chronic Breast Toxicity After Intraoperative Radiation Therapy (IORT) as a Single Modality or as a Boost Using the Intrabeam\u00ae Device: A Prospective Study","volume":"24","author":"Key","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10549-012-2168-4","article-title":"Late Radiation Toxicity after Intraoperative Radiotherapy (IORT) for Breast Cancer: Results from the Randomized Phase III Trial TARGIT A","volume":"135","author":"Sperk","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijrobp.2006.05.042","article-title":"Long-Term Toxicity of an Intraoperative Radiotherapy Boost Using Low Energy X-Rays during Breast-Conserving Surgery","volume":"66","author":"Bauer","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.radonc.2017.07.001","article-title":"Whole Breast Radiotherapy in the Lateral Isocentric Lateral Decubitus Position: Long-Term Efficacy and Toxicity Results","volume":"124","author":"Bronsart","year":"2017","journal-title":"Radiother. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/0284186X.2019.1695061","article-title":"Hypofractionated Whole Breast Irradiation after Conservative Surgery for Patients Aged Less than 60 Years: A Multi-Centre Comparative Study","volume":"59","author":"Meattini","year":"2020","journal-title":"Acta Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10549-017-4118-7","article-title":"Hypofractionated Whole Breast Radiotherapy in Breast Conservation for Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Trials","volume":"162","author":"Valle","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated Breast Radiotherapy for 1 Week versus 3 Weeks (FAST-Forward): 5-Year Efficacy and Late Normal Tissue Effects Results from a Multicentre, Non-Inferiority, Randomised, Phase 3 Trial","volume":"395","author":"Haviland","year":"2020","journal-title":"Lancet"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1200\/JCO.2007.11.4991","article-title":"Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost versus No Boost EORTC 22881-10882 Trial","volume":"25","author":"Bartelink","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","article-title":"Whole-Breast Irradiation with or without a Boost for Patients Treated with Breast-Conserving Surgery for Early Breast Cancer: 20-Year Follow-up of a Randomised Phase 3 Trial","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated Versus Standard Fractionated Radiotherapy in Patients with Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus Conventional Fractionated Postmastectomy Radiotherapy for Patients with High-Risk Breast Cancer: A Randomised, Non-Inferiority, Open-Label, Phase 3 Trial","volume":"20","author":"Wang","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1200\/JCO.20.01024","article-title":"Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial from China","volume":"38","author":"Wang","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.breast.2016.03.002","article-title":"Impact of Tumour Bed Boost Integration on Acute and Late Toxicity in Patients with Breast Cancer: A Systematic Review","volume":"27","author":"Hamilton","year":"2016","journal-title":"Breast"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s12282-018-0923-z","article-title":"Hypofractionated Whole Breast Radiotherapy with or without Hypofractionated Boost in Early Stage Breast Cancer Patients: A Mono-Institutional Analysis of Skin and Subcutaneous Toxicity","volume":"26","author":"Palumbo","year":"2019","journal-title":"Breast Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2016.12.023","article-title":"Does an Integrated Boost Increase Acute Toxicity in Prone Hypofractionated Breast Irradiation? A Randomized Controlled Trial","volume":"122","author":"Paelinck","year":"2017","journal-title":"Radiother. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2016.02.027","article-title":"Acute Skin Toxicity Associated with a 1-Week Schedule of Whole Breast Radiotherapy Compared with a Standard 3-Week Regimen Delivered in the UK FAST-Forward Trial","volume":"120","author":"Brunt","year":"2016","journal-title":"Radiother. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.breast.2016.07.013","article-title":"Factors Influencing Acute and Late Toxicity in the Era of Adjuvant Hypofractionated Breast Radiotherapy","volume":"29","author":"Bonfantini","year":"2016","journal-title":"Breast"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1748-717X-7-217","article-title":"Factors of Influence on Acute Skin Toxicity of Breast Cancer Patients Treated with Standard Three-Dimensional Conformal Radiotherapy (3D-CRT) after Breast Conserving Surgery (BCS)","volume":"7","author":"Sfintizky","year":"2012","journal-title":"Radiat. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-006-9480-9","article-title":"Predictive Factors for Late Normal Tissue Complications Following Radiotherapy for Breast Cancer","volume":"106","author":"Lilla","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.radonc.2018.06.020","article-title":"Predictors for Poor Cosmetic Outcome in Patients with Early Stage Breast Cancer Treated with Breast Conserving Therapy: Results of the Young Boost Trial","volume":"128","author":"Brouwers","year":"2018","journal-title":"Radiother. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.breast.2013.07.047","article-title":"Smoking as an Independent Risk Factor for Severe Skin Reactions Due to Adjuvant Radiotherapy for Breast Cancer","volume":"22","author":"Sharp","year":"2013","journal-title":"Breast"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"102291","DOI":"10.1016\/j.ctim.2019.102291","article-title":"Vitamin D and Selenium Blood Levels and Acute Skin Toxicity during Radiotherapy for Breast Cancer","volume":"49","author":"Momm","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0360-3016(94)90312-3","article-title":"Dose and Volume Effects on Fibrosis after Breast Conservation Therapy","volume":"30","author":"Borger","year":"1994","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.ejca.2008.07.032","article-title":"Predictors of the Risk of Fibrosis at 10 Years after Breast Conserving Therapy for Early Breast Cancer: A Study Based on the EORTC Trial 22881-10882 \u201cBoost versus No Boost\u201d","volume":"44","author":"Collette","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/ijc.23138","article-title":"Genetic Predictors of Long-Term Toxicities after Radiation Therapy for Breast Cancer","volume":"122","author":"Kuptsova","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1158\/1078-0432.CCR-06-1244","article-title":"Late Toxicity Is Not Increased in BRCA1\/BRCA2 Mutation Carriers Undergoing Breast Radiotherapy in the United Kingdom","volume":"12","author":"Shanley","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Terrazzino, S., Cargnin, S., Deantonio, L., Pisani, C., Masini, L., Canonico, P.L., Genazzani, A.A., and Krengli, M. (2019). Impact of ATM Rs1801516 on Late Skin Reactions of Radiotherapy for Breast Cancer: Evidences from a Cohort Study and a Trial Sequential Meta-Analysis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0225685"},{"key":"ref_53","first-page":"299","article-title":"Breast Cancer Adjuvant Radiotherapy in BRCA1\/2, TP53, ATM Genes Mutations: Are There Solved Issues?","volume":"13","author":"Lazzari","year":"2021","journal-title":"Breast Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.canrad.2009.04.003","article-title":"Importance of local skin treatments during radiotherapy for prevention and treatment of radio-induced epithelitis","volume":"13","author":"Chargari","year":"2009","journal-title":"Cancer Radiother."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2011.05.014","article-title":"Can We Decrease the Skin Reaction in Breast Cancer Patients Using Hyaluronic Acid during Radiation Therapy? Results of Phase III Randomised Trial","volume":"100","author":"Kirova","year":"2011","journal-title":"Radiother. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaad.2019.02.047","article-title":"Management of Acute Radiation Dermatitis: A Review of the Literature and Proposal for Treatment Algorithm","volume":"81","author":"Rosenthal","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00520-012-1622-5","article-title":"Topical Agent Therapy for Prevention and Treatment of Radiodermatitis: A Meta-Analysis","volume":"21","author":"Zhang","year":"2013","journal-title":"Support. Care Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.radonc.2015.08.028","article-title":"Hydrosorb\u00ae versus Control (Water Based Spray) in the Management of Radio-Induced Skin Toxicity: Results of Multicentre Controlled Randomized Trial","volume":"117","author":"Bazire","year":"2015","journal-title":"Radiother. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ebiom.2015.10.024","article-title":"Radiation-Induced CD8 T-Lymphocyte Apoptosis as a Predictor of Breast Fibrosis after Radiotherapy: Results of the Prospective Multicenter French Trial","volume":"2","author":"Azria","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"15757","DOI":"10.18632\/oncotarget.24606","article-title":"Impact of Adjuvant Hormonotherapy on Radiation-Induced Breast Fibrosis According to the Individual Radiosensitivity: Results of a Multicenter Prospective French Trial","volume":"9","author":"Bourgier","year":"2018","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.radonc.2016.09.019","article-title":"Evaluation of Acute Skin Toxicity in Breast Radiotherapy with a New Quantitative Approach","volume":"122","year":"2017","journal-title":"Radiother. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1118\/1.3633942","article-title":"Spectrophotometer and Ultrasound Evaluation of Late Toxicity Following Breast-Cancer Radiotherapy","volume":"38","author":"Yoshida","year":"2011","journal-title":"Med. Phys."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1756-9966-32-80","article-title":"Evidence from a Breast Cancer Hypofractionated Schedule: Late Skin Toxicity Assessed by Ultrasound","volume":"32","author":"Landoni","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1259\/bjr\/28583675","article-title":"An investigation into methods of IMRT planning applied to breast radiotherapy","volume":"81","author":"Donovan","year":"2008","journal-title":"Br. J. Radiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.clon.2016.02.011","article-title":"The Cambridge Breast Intensity-modulated Radiotherapy Trial: Comparison of Clinician- versus Patient-reported Outcomes","volume":"28","author":"Mukesh","year":"2016","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"390","author":"Coles","year":"2017","journal-title":"Lancet"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/23\/5928\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:35:50Z","timestamp":1760168150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/23\/5928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":66,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["cancers13235928"],"URL":"https:\/\/doi.org\/10.3390\/cancers13235928","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]}}}